Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for REM sleep behaviour disorder
ACTRN12613000647730Phase 2Terminated
- Sponsor
- Woolcock Institute of Medical Research
- Start
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in REM sleep behavior disorder (RBD) comparing Circadin with Placebo (2 arms). Primary endpoint: Change in total recorded REM sleep behaviour disorder events. Started Oct 2014; status: terminated.
02
Drugs
melatonin
03
Conditions
REM sleep behavior disorder (RBD)
Beyond the preview
Go deeper on ACTRN12613000647730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613000647730.